WO2003026537A1 - Breast prosthesis filled with fibers - Google Patents

Breast prosthesis filled with fibers Download PDF

Info

Publication number
WO2003026537A1
WO2003026537A1 PCT/IL2002/000776 IL0200776W WO03026537A1 WO 2003026537 A1 WO2003026537 A1 WO 2003026537A1 IL 0200776 W IL0200776 W IL 0200776W WO 03026537 A1 WO03026537 A1 WO 03026537A1
Authority
WO
WIPO (PCT)
Prior art keywords
fibers
implant
mplant
breast
implants
Prior art date
Application number
PCT/IL2002/000776
Other languages
French (fr)
Inventor
Avishai Weinberger
Revital Tucker
Original Assignee
Avishai Weinberger
Revital Tucker
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avishai Weinberger, Revital Tucker filed Critical Avishai Weinberger
Publication of WO2003026537A1 publication Critical patent/WO2003026537A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/12Mammary prostheses and implants

Definitions

  • the present invention relates to prosthetic implants in general and prosthetic breast implants, in particular.
  • Implant rupture or leakage can be due to an injury or just normal wear - even the pressure of a mammogram can contribute to implant rupture.
  • Plastic surgeons usually recommend the removal of a ruptured implant even if the silicone is still enclosed within the scar tissue capsule, because the silicone gel may eventually leak into surrounding tissue.
  • Saline implants have been known to become infected and leak, often causing infection in surrounding tissues.
  • Silicone breast implants are known to be associated with calcium deposits in the breast. These calcium deposits can make it even more difficult to obtain a clear mammogram and can be mistaken for possible cancer (necessitating additional surgery or biopsy). Although the calcium deposits do not appear to be harmful, they can be indicative of a nearby cancer. Therefore, the presence of silicone implants may make it difficult to distinguish between the predictable effects of the implant and actual evidence of cancer. It is, therefore, the general object of the invention to overcome these and other deficiencies common to conventional breast implants.
  • the breast implant will not interfere with x-ray and mammogram examinations.
  • a prosthesis for physical implant comprising an outer envelope and a filler of a yieldable non-liquid substance.
  • the filler substance will consist of a fibrous material, e.g. cotton.
  • the density of the fibrous material may be uniform, or may vary with respect to a different location.
  • the outer envelope will be of rough surface silicone.
  • Fig. 1 is a perspective view of a fiber filled breast implant prosthesis
  • Fig. 2 is a top view of the implant prosthesis of Fig. 1
  • Fig. 3 is a side view of the implant prosthesis of Fig. 1;
  • Fig. 4 is a schematic cross-section of the breast implant prosthesis of Fig. 1;
  • the prosthesis generally designated A comprises an outer envelope B of rough surface silicone, which may be of the conventional type commonly used in prevailing prosthetic implants.
  • the envelope B is filled with a fibrous material C, preferably of cotton or synthetic fibers such as DacronTM, or GortexTM (the latter two are currently widely used for surgical stitching procedures); however, any other fibrous material of similar character to those noted above may be employed.
  • a fibrous material C preferably of cotton or synthetic fibers such as DacronTM, or GortexTM (the latter two are currently widely used for surgical stitching procedures); however, any other fibrous material of similar character to those noted above may be employed.
  • the silicone envelope B is filled with the fiber content whereby the filling retains a uniform texture and density, with a flexible propensity to return to the conscripting shape of the encasing envelope.
  • the method employed for filling the envelope B is by encasing or "trapping" various sized fibers C or fiber aggregates.
  • Envelope B is seamlessly and hermetically sealed to prevent direct contact with body tissue.
  • the 'solid' nature of the fiber implant provides a solution to the problem of 'leakage' penetrating surrounding tissue, a problem commonly associated with conventional breast implants, and will offer a greater 'lifespan' thereby diminishing the need for replacement surgery at irregular and close intervals.
  • the dense fibers also provide a solution to breast x-ray and mammogram examinations, since the cotton, GortexTM , DacronTM, and similar fibers are radiolucent.
  • the fiber filling has a specific gravity much lower than lgr/cm 3 and will therefore virtually eliminate the problem of 'sagging' that plagues both the natural as well as the conventional saline water or other liquid substances filled implanted breasts.
  • the unattractive 'wavy' appearance will disappear in most if not all implants due to the especially light yet dense composition of the encased prostheses.
  • the fiber implants will retain a structural integrity and will provide strength and stability over significantly longer periods of time, precluding the necessity of repetitive cosmetic surgeries.
  • the fiber implant is virtually maintenance free and has the quality of reproducing a tactile response similar to breast tissue - providing additional attractive incentive for use as a preferred breast prosthesis for implant.
  • Fiber fillings also afford the unique ability to be prepared as layers with varying degrees of flexibility or firmness. This can be achieved by fusing or otherwise binding non-homogeneous layers of filling each comprised of loose, bulk, or aggregated fibers of differing strength, density, length, etc. - all with a view of achieving the optimal result for the individual patient.
  • the solid/non-fluid components of the implant are lightweight, shaped, elastic, long lasting and do not interfere with x-ray and mammogram examinations.

Abstract

A prosthesis for physical implant (A), comprising an outer envelope (B) and a filler substance that consists of a fibrous material (C). The density of the fibrous material (C) may be uniformor may vary. Preferably, the outer envelope (B) consists of rough surface silicone.

Description

BREAST PROSTHESIS FILLED WITH FIBERS
BACKGROUND OF THE INVENTION
The present invention relates to prosthetic implants in general and prosthetic breast implants, in particular.
Breast implants, routinely in use today, characteristically have a life expectancy of up to 10-12 years. The fluid or gel implants currently in use have a tendency to 'leak', pervading neighboring tissue at a rate of approximately lcc per year. Whereas a breast implant may rupture or leak any time after surgery the incidental rate is approximately 5% at five years increasing dramatically as the implant ages achieving a rupture rate of nearly 70% by approximately 10 years. Since most recipients have two implants, the incidence of leakage or rupture is compounded for each recipient so that nearly one in four women may require additional surgery due to complications within five years of receiving implants and three out of four women may required additional surgery by 10 years. Implant rupture or leakage can be due to an injury or just normal wear - even the pressure of a mammogram can contribute to implant rupture. Plastic surgeons usually recommend the removal of a ruptured implant even if the silicone is still enclosed within the scar tissue capsule, because the silicone gel may eventually leak into surrounding tissue. Saline implants have been known to become infected and leak, often causing infection in surrounding tissues.
Aside from the known risks associated with surgery, the repeated corrective surgeries to improve or repair the damaged prosthesis may additionally result in an unsatisfactory cosmetic outcome.
From another angle, it is well known that the female breasts tend to "sag" with age (with or without a prosthetic implant). Prosthetic implants widely in use today, are relatively heavy and difficult for the breast skin and tissue to bear - causing the breast tissue to thin and shrink. After a relatively short period of time the breast begins to "sag", which in turn causes the skin to stretch, becoming thinner. The thinner the skin becomes the easier it becomes to physically and visibly discern the implant. Sometimes the skin shows evidence of 'waves' particularly in saline solution implants, but also in silicone gel and sometimes in cohesive implants. Another deficiency of conventional breast implants is that they are non-receptive to x-ray and ultra-sound mammary examination, periodical examinations recognized as essential to women's health. Silicone breast implants are known to be associated with calcium deposits in the breast. These calcium deposits can make it even more difficult to obtain a clear mammogram and can be mistaken for possible cancer (necessitating additional surgery or biopsy). Although the calcium deposits do not appear to be harmful, they can be indicative of a nearby cancer. Therefore, the presence of silicone implants may make it difficult to distinguish between the predictable effects of the implant and actual evidence of cancer. It is, therefore, the general object of the invention to overcome these and other deficiencies common to conventional breast implants.
It is a further object of the present invention to provide a lighter breast implant, such that the breast can withstand the weight of the implant for a longer period of time, thereby prolonging the attractive cosmetic effect thereof. It is a further object of the present invention to achieve a stable breast implant design that will not 'wave'.
It is a further object of the present invention to prevent any kind of 'leakage' and subsequent penetration of body tissues.
It is yet a further object of the invention that the breast implant will not interfere with x-ray and mammogram examinations.
SUMMARY OF THE INVENTION
A prosthesis for physical implant, comprising an outer envelope and a filler of a yieldable non-liquid substance. Preferably, the filler substance will consist of a fibrous material, e.g. cotton. The density of the fibrous material may be uniform, or may vary with respect to a different location.
Preferably the outer envelope will be of rough surface silicone.
BRIEF DESCRIPTION OF THE DRAWINGS:
These and additional constructional features and advantages of the invention become readily understood in the light of the ensuing description of a preferred embodiment thereof, given by way of example only with reference to the accompanying drawings, wherein -
Fig. 1 is a perspective view of a fiber filled breast implant prosthesis; Fig. 2 is a top view of the implant prosthesis of Fig. 1; Fig. 3 is a side view of the implant prosthesis of Fig. 1; and
Fig. 4 is a schematic cross-section of the breast implant prosthesis of Fig. 1;
DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
As shown in Figs. 1-3, the prosthesis generally designated A comprises an outer envelope B of rough surface silicone, which may be of the conventional type commonly used in prevailing prosthetic implants.
Unlike the conventional implants, the envelope B is filled with a fibrous material C, preferably of cotton or synthetic fibers such as Dacron™, or Gortex™ (the latter two are currently widely used for surgical stitching procedures); however, any other fibrous material of similar character to those noted above may be employed.
The silicone envelope B is filled with the fiber content whereby the filling retains a uniform texture and density, with a flexible propensity to return to the conscripting shape of the encasing envelope. The method employed for filling the envelope B is by encasing or "trapping" various sized fibers C or fiber aggregates. Envelope B is seamlessly and hermetically sealed to prevent direct contact with body tissue.
The 'solid' nature of the fiber implant provides a solution to the problem of 'leakage' penetrating surrounding tissue, a problem commonly associated with conventional breast implants, and will offer a greater 'lifespan' thereby diminishing the need for replacement surgery at irregular and close intervals.
The dense fibers also provide a solution to breast x-ray and mammogram examinations, since the cotton, Gortex™ , Dacron™, and similar fibers are radiolucent.
The fiber filling has a specific gravity much lower than lgr/cm3 and will therefore virtually eliminate the problem of 'sagging' that plagues both the natural as well as the conventional saline water or other liquid substances filled implanted breasts. The unattractive 'wavy' appearance will disappear in most if not all implants due to the especially light yet dense composition of the encased prostheses. The fiber implants will retain a structural integrity and will provide strength and stability over significantly longer periods of time, precluding the necessity of repetitive cosmetic surgeries.
The fiber implant is virtually maintenance free and has the quality of reproducing a tactile response similar to breast tissue - providing additional attractive incentive for use as a preferred breast prosthesis for implant.
Fiber fillings also afford the unique ability to be prepared as layers with varying degrees of flexibility or firmness. This can be achieved by fusing or otherwise binding non-homogeneous layers of filling each comprised of loose, bulk, or aggregated fibers of differing strength, density, length, etc. - all with a view of achieving the optimal result for the individual patient.
Surgeons will be able to order tailored implants manufactured to order according to specifications such as exact dimensions, shape, size, flexibility, weight, and other parameters. It has thus been established that the invention as herein disclosed, provides for an alternative to the prevailing composition of implants in general and breast implants, in particular. The solid/non-fluid components of the implant are lightweight, shaped, elastic, long lasting and do not interfere with x-ray and mammogram examinations.
It should be appreciated that the present invention is capable of being applied in the form of a variety of embodiments, only one of which has been illustrated and described above. The invention may be embodied in other forms without departing from its spirit or essential characteristics. The described embodiment is to be considered in all respects only as illustrative and not restrictive. The scope of the invention is, therefore, indicated by the appended claims rather than by the foregoing description. All changes, which come within the meaning and range of equivalency of the claims, are to be embraced within their scope.

Claims

WHAT IS CLAIMED IS:
1. A prosthesis for physical implant (A), comprising an outer envelope (B) and a filler, characterized in that the filler comprises a yieldable non-liquid substance (C).
2. The implant as claimed in Claim 1 being a breast prosthesis.
3. The implant of Claim 1 the substance comprises a fibrous material.
4. The implant as claimed in Claim 3 wherein the fibrous material comprises cotton fibers.
5. The implant as claimed in Claim 3 wherein the fibrous material comprises synthetic fibers.
6. The mplant as claimed in Claim 3 wherein the fibers are aggregated.
7. The mplant as claimed in Claim 3 wherein the fibers are disbursed in bulk form.
8. The mplant as claimed in Claim 3 wherein the fibers are evenly disbursed.
9. The mplant as claimed in Claim 3 wherein the fibers are of a variable density.
10. The mplant as claimed in Claim 3 wherein the fibers are layered.
11. The mplant as claimed in Claim 3 wherein the fibers are shaped.
12. The mplant as claimed in Claim 3 wherein the fibers are fused.
13. The mplant as claimed in Claim 3 wherein the fibers are bonded.
14. The mplant as claimed in Claim 1 wherein the envelope has a thin non-permeable, silicone.
15. The implant as claimed in Claim 1 wherein the envelope has a rough surface.
PCT/IL2002/000776 2001-09-24 2002-09-19 Breast prosthesis filled with fibers WO2003026537A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL14557601A IL145576A0 (en) 2001-09-24 2001-09-24 A prosthesis for physical implant
IL145576 2001-09-24

Publications (1)

Publication Number Publication Date
WO2003026537A1 true WO2003026537A1 (en) 2003-04-03

Family

ID=11075807

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2002/000776 WO2003026537A1 (en) 2001-09-24 2002-09-19 Breast prosthesis filled with fibers

Country Status (2)

Country Link
IL (1) IL145576A0 (en)
WO (1) WO2003026537A1 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006135998A2 (en) * 2005-06-24 2006-12-28 Wagenfuhr Jr J Implantable prosthesis with double convexity
WO2008112705A2 (en) * 2007-03-15 2008-09-18 Uluru, Inc. Method of formation of viscous, shape conforming gels and their uses as medical prosthesis
US7811605B2 (en) 2002-11-06 2010-10-12 Uluru Inc. Method of formation of shape-retentive aggregates of gel particles and their uses
US7910135B2 (en) 2006-10-13 2011-03-22 Uluru Inc. Hydrogel wound dressing and biomaterials formed in situ and their uses
WO2012054424A2 (en) * 2010-10-18 2012-04-26 Leidiez, LLC Novel enhanced filamentous silicone products and processes
CN102470032A (en) * 2009-07-21 2012-05-23 生命细胞公司 Graft materials for surgical breast procedures
US8501645B2 (en) 2005-06-30 2013-08-06 Donna K. Jackson Enhanced filamentous silicone products and processes

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171269A (en) * 1991-08-29 1992-12-15 Medical Engineering Corporation Mammary prosthesis
US5545217A (en) * 1995-04-20 1996-08-13 C.M. Offray & Son, Inc. Breast implant
US5676698A (en) * 1993-09-07 1997-10-14 Datascope Investment Corp. Soft tissue implant
US5961552A (en) * 1997-08-02 1999-10-05 Pmt Corporation Internally configured prosthesis
WO2000033771A2 (en) * 1998-12-11 2000-06-15 Johnson Gerald W Implants filled with solid or semi-solid material

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171269A (en) * 1991-08-29 1992-12-15 Medical Engineering Corporation Mammary prosthesis
US5676698A (en) * 1993-09-07 1997-10-14 Datascope Investment Corp. Soft tissue implant
US5545217A (en) * 1995-04-20 1996-08-13 C.M. Offray & Son, Inc. Breast implant
US5961552A (en) * 1997-08-02 1999-10-05 Pmt Corporation Internally configured prosthesis
WO2000033771A2 (en) * 1998-12-11 2000-06-15 Johnson Gerald W Implants filled with solid or semi-solid material

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7811605B2 (en) 2002-11-06 2010-10-12 Uluru Inc. Method of formation of shape-retentive aggregates of gel particles and their uses
WO2006135998A2 (en) * 2005-06-24 2006-12-28 Wagenfuhr Jr J Implantable prosthesis with double convexity
WO2006135998A3 (en) * 2005-06-24 2007-03-01 Jr J Wagenfuhr Implantable prosthesis with double convexity
US8501645B2 (en) 2005-06-30 2013-08-06 Donna K. Jackson Enhanced filamentous silicone products and processes
US7910135B2 (en) 2006-10-13 2011-03-22 Uluru Inc. Hydrogel wound dressing and biomaterials formed in situ and their uses
WO2008112705A2 (en) * 2007-03-15 2008-09-18 Uluru, Inc. Method of formation of viscous, shape conforming gels and their uses as medical prosthesis
WO2008112705A3 (en) * 2007-03-15 2009-03-12 Uluru Inc Method of formation of viscous, shape conforming gels and their uses as medical prosthesis
CN102470032A (en) * 2009-07-21 2012-05-23 生命细胞公司 Graft materials for surgical breast procedures
WO2012054424A2 (en) * 2010-10-18 2012-04-26 Leidiez, LLC Novel enhanced filamentous silicone products and processes
WO2012054424A3 (en) * 2010-10-18 2012-08-30 Leidiez, LLC Novel enhanced filamentous silicone products and processes

Also Published As

Publication number Publication date
IL145576A0 (en) 2002-06-30

Similar Documents

Publication Publication Date Title
EP1592365B1 (en) Solid implant
US5391203A (en) Method of draining and filling soft tissue implant
EP0320133B1 (en) Breast prosthesis with multiple lumens
EP1424046B1 (en) Breast prosthesis
US3934274A (en) Deflatable mammary augmentation prosthesis
Gylbert et al. Capsular contracture after breast reconstruction with silicone-gel and saline-filled implants: a 6-year follow-up
US5496370A (en) Gel-like prosthetic device
US5545221A (en) Apparatus and method for implant prostheses
US9750600B2 (en) Breast implant
Sˇmahel Histology of the capsules causing constrictive fibrosis around breast implants
Worseg et al. Long term results of inflatable mammary implants
WO2003026537A1 (en) Breast prosthesis filled with fibers
Pennisi Long-term use of polyurethane breast prostheses: A 14-year experience
Copeland et al. Systemic inflammatory disorder related to fibrous breast capsules after silicone implant removal
Shaaban et al. Leakage and silicone lymphadenopathy with cohesive breast implant
AU707238B2 (en) Breast implant device
Glatt et al. Long-term follow-up of a sponge breast implant and review of the literature
CN109745147B (en) Method for manufacturing full-autologous tissue double-layer envelope conformable breast prosthesis
Mutou Augmentation mammaplasty with the Akiyama prosthesis
Muller Hydrogel-filled mammary prosthesis
McGregor et al. Observations on a consecutive series of patients who have had Trilucent breast implants removed as recommended by the MDA Hazard Notice (May 2000)
CN201798826U (en) Breast prosthesis
CA1094252A (en) Deflatable tissue augmentation prosthesis

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VC VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP